A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Clinical trial NCT06716307 · COMPLETED
Trial details
- NCT number
- NCT06716307
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2025-03-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.